REFERÊNCIAS 1 GORDON, Leslie Manual sobre Progéria. 2ª ed. Boston: Progéria Research Foundation, 2019. 2 LAMIS, Aselah ; SIDDIQUI, Shiza W .; ASHOK, Tejaswini ; PATNI, Nassar ; FATIMA, Mahejabeen ; ANEEF, Asiff Nathi. Hutchinson - Gilford Progeria Syndrome: A Literature Review . Cureus, [S. l.], v. 14, n. 8, e28629, 31 ago. 2022. DOI: 10.7759/cureus.28629. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC9524302/. Acesso em: 4 jun. 2025. 3 MENEZES, Deborah Antunes de ; CAIXETA, Amanda Ramos ; SILVA, Isabella de Brito Alem ; SOUZA, Ana Luísa de ; RIBEIRO, Carolina Pessoa Rodrigues ; SILVA, Larissa Amorim ; DUARTE, Letícia Araújo ; RIBEIRO, Viviane de Oliveira ; SOUZA, Gracielly Barros Vasques de ; EVANGELISTA, Grazielly Soares ; SAMPAIO, Guilherme Albuquerque ; SANTOS, G uilherme Victor dos ; MENDONÇA, Natália Santana Daher Síndrome Progeroide de Hutchinson - Gilford: uma revisão integrativa . Brazilian Journal of Health Review, [S. l.], v. 4, n. 5, p. 268 – 280, 2021. DOI: 10.34119/bjhrv4n5 - 268. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/download/37280/pdf/96 662. Acesso em: 21 maio 2025. 4 SUZUKI, Mari et al. FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson - Gilford progeria syndrome and processing - deficient progeroid laminopathies . Clinical Cancer Research, [S. l.], 2023. Disponível em: https://www.sciencedirect.com/science/article/pii/S1556086423000275. Acesso em: 22 maio 2025. 5 TALUKDER, Pratik ; SAHA, Arunima ; ROY, Sohini ; GHOSH, Gargi ; DUTTA ROY, Debshikha ; BARUA, Snejuti Microbial Biofilm Formation and Its Role in Contaminant Biodegradation . Applied Biochemistry and Biotechnology, [S. l.], v. 194, p. 1458 – 1473, 2022. Disponível em: https://link.springer.com/article/10.1007/s12010 - 021 - 03514 - y. Acesso em: 6 jun. 2025.